CC BY 4.0 · Aorta (Stamford) 2020; 08(05): 144-147
DOI: 10.1055/s-0040-1714124
Case Report

Surgical Single Stage Treatment for Obstructive Hypertrophic Cardiomyopathy and Aortic Arch Aneurysm

1   Department of Cardiology, Policlinico di Monza, Monza, Italy
2   Department of Cardiology, Fondazione Policlinico San Matteo, Pavia, Italy
,
Valerio Stefano Tolva
3   Department of Vascular Surgery, Policlinico di Monza, Monza, Italy
,
Giuseppe Vaccari
4   Department of Cardiac Surgery, Policlinico di Monza, Monza, Italy
,
Paolo Bianchi
3   Department of Vascular Surgery, Policlinico di Monza, Monza, Italy
,
Renato Casana
5   Vascular Surgery Research Laboratory, Istituto Auxologico Italiano, Milano, Italy
,
Gianfranco Parati
6   Cardiology Unit and Department of Cardiovascular, Neural and Metabolic Science, Istituto Auxologico Italiano, S. Luca Hospital, Milano, Italy
,
Paolo Ferrazzi
4   Department of Cardiac Surgery, Policlinico di Monza, Monza, Italy
› Author Affiliations
Funding None.

Abstract

Coexistence of obstructive hypertrophic cardiomyopathy and severe aortic pathology is extremely rare; nonetheless, the association between these two diseases is fascinating. Here we present a unique case report of a patient with obstructive hypertrophic cardiomyopathy and aortic arch aneurysm treated by a single surgical procedure.



Publication History

Received: 29 October 2019

Accepted: 30 May 2020

Article published online:
23 December 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Geske JB, Ommen SR, Gersh BJ. Hypertrophic cardiomyopathy: clinical update. JACC Heart Fail 2018; 6 (05) 364-375
  • 2 Yousefzai R, Agarwal A, Fuad Jan M. et al. Hypertrophic cardiomyopathy with aortic dilation: a novel observation. Eur Heart J Cardiovasc Imaging 2017; 18 (12) 1398-1403
  • 3 Boonyasirinant T, Rajiah P, Setser RM. et al. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging. J Am Coll Cardiol 2009; 54 (03) 255-262
  • 4 Ferrazzi P, Spirito P, Iacovoni A. et al. Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy. J Am Coll Cardiol 2015; 66 (15) 1687-1696
  • 5 Maron BJ, Yacoub M, Dearani JA. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients. Eur Heart J 2011; 32 (09) 1055-1058
  • 6 Jones JA, Spinale FG, Ikonomidis JS. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res 2009; 46 (02) 119-137
  • 7 Hiratzka LF, Bakris GL, Beckman JA. et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, Society for Vascular Medicine. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121 (13) e266-e369